DSIP
Research use only.
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide widely studied for its role in regulating sleep architecture and modulating physiological responses to stress. In research settings, DSIP is primarily investigated for its potential influence on sleep cycles, hormonal balance, and central nervous system signaling.
Product overview
DSIP is a research-grade peptide composed of a 9-amino-acid sequence, engineered for stability and biological activity. Preclinical research associates DSIP with modulation of sleep-wake cycles, endocrine regulation, and stress adaptation pathways. Its involvement in both central nervous system and hormonal signaling makes it a valuable tool in sleep and neuroendocrine research.
Key research features
Sleep regulation and circadian research:
DSIP is widely studied for its potential role in influencing sleep onset, sleep quality, and sleep architecture in experimental models.
Stress and neuroendocrine signaling:
Studies suggest DSIP may modulate hypothalamic-pituitary-adrenal (HPA) axis activity, making it relevant for research into stress adaptation and hormonal regulation.
CNS and recovery pathways:
Research indicates DSIP may influence central nervous system recovery processes and neuronal signaling balance, supporting studies focused on restorative physiology and neurological resilience.
DSIP (Delta Sleep-Inducing Peptide) – Suggested Use (Research Context)
Typical Dose: 100–300 mcg per day
Route: Subcutaneous injection
Frequency: Once daily (often before bed)
Duration: As directed by a qualified professional